Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
45 Cards in this Set
- Front
- Back
Cancer cell cycle specific agents include:
|
antimetabolites, bleomycin, podophyllin alkaloids, and plant alkaloids
|
|
Cancer cell cycle nonspecific agents include:
|
alkylating agents, antibiotics, cisplatin, nitrosoureas
|
|
drugs that reverse MDR (multi-drug resistance) include:
|
verapamil, quinidine, and cyclosporine
|
|
Mechanism of Action:
Alkylate within DNA at the N7 position of guanine miscoding through abnormal base-pairing with thymine or in depurination by excision of guanine residues, leading to strand breakage |
Alkylating agents
|
|
alkylating agents include:
|
Nitrogen Mustards
Cyclophosphamide Ethylenimines Thiotepa Alkyl Sulfonates Busulfan Nitrosoureas Carmustine |
|
Precursor of an alkylating nitrogen mustard antineoplastic
Use: immunosuppressive agent that must be activated in the liver to form the active aldophosphamide. |
cyclophosphamide (nitrogen mustard)
|
|
Positional isomer of cyclophosphamide
Use: is active as an alkylating agent and an immunosuppressive agent |
Ifosfamide (nitrogen mustard)
|
|
A necrotizing irritant destructive to mucous membranes.
Use: It was formerly used as a war gas. The hydrochloride is used as an anti-neoplastic in Hodgkin's disease and lymphomas. |
Mechlorethamine
|
|
An alkylating nitrogen mustard that
Use is used as an anti-neoplastic in the form of the levo isomer - melphalan Toxicity the racemic mixture and the dextro isomer are toxic to bone marrow potential carcinogen |
Melphalan
|
|
A nitrogen mustard alkylating agent
Use: used as anti-neoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. |
Chlorambucil
|
|
Nitrosoureas include:
|
Carmustine, Lomustine, Semustine, and Streptozocin-naturally occuring sugar containing
|
|
Common toxicity of alkylating agents include:
|
Bone marrow depression, with leukopenia and thrombocytopenia
|
|
These drugs can cause hemorrhagic cystitis
Reduced by coadministration with MESNA |
Cyclophosphamide and Ifosfamide
|
|
These drugs are ototoxic and nephrotoxic
Nephrotoxicity reduced by chloride diuresis and hydration |
Cisplatin and Carboplatin
|
|
Alkylating agent used to treat ovarian cancer
|
Thiotepa
|
|
Alkylating agent used to treat chronic myeloid leukemia
|
Busulfan:
|
|
Alkylating agent used to treat brain tumors
|
Nitrosoureas
|
|
Alkylating agent used to treat insulin secreting islet cell carcinoma of the pancreas
|
Streptozocin
|
|
Antimetabolites include:
|
Folic Acid Analogs
Purine Analogs Pyrimidine Analogs |
|
Folic acid analogs include:
|
Methotrexate
Trimetrexate Pemetrexed |
|
An essential dietary factor, from which THF cofactors are formed which provide single carbon groups for the synthesis of precursors of DNA and RNA
Is reduced by DHFR |
Folate
|
|
MOA: prevents the formation of THF, causing an intracellular deficiency of folate coenzymes and accumulation of the toxic inhibitory substrate, DHF polyglutamate
The one carbon transfer reactions for purine and thymidylate synthesis cease, interrupting DNA and RNA synthesis Primarily occurs in the enzyme DHFR |
Methotrexate
|
|
Ways that cells can become resistant to methotrexate:
|
Decreased drug transport through the reduced folate carrier or folate receptor protein
Decreased formation of cytotoxic MTX polyglutamates Increased levels of the target enzyme DHFR through gene amplification and other genetic mechanisms Altered DHFR protein with reduced affinity for MTX |
|
Methotrexate is used to treat:
|
psoriasis, RA, Burkitt's and non-Hodgkins lymphomas, cancer of breast, head, neck, ovary, and bladder
|
|
To treat bone marrow suppression associated with methotrexate you should administer?
To treat nephrotoxicity you should administer? |
leucovorin (folinic acid)
Sodium Bicarbonate to alkalinize the urine |
|
Pemetrexed is used to treat?
|
Mesothelioma
|
|
Purine antagonist include?
|
6-thiopurines
6-Mercaptopurine 6-Thioguanine Fludarabine Phosphate Cladribine |
|
Must be metabolized by hypoxantine-guanine phosphoribosyl transferase (HGPRT) to the nucleotide form
This form inhibits numerous enzymes of purine nucleotide interconversion |
6-Mercaptopurine
6-Thioguanine |
|
M.O.A.- phosphorylated intracellularly by deoxycytidine kinase to the triphosphate form
The metabolite inhibits DNA polymerase ribonucleotide reductase Induces apoptosis Use non-Hodgkin’s lymphoma chronic lymphocytic leukemia |
Fludarabine Phosphate
|
|
An antineoplastic agent
M.O.A. -phosphorylated by deoxycytidine kinase and is incorporated into DNA Causes DNA strand breaks Use hairy cell leukemia chronic lymphocytic leukemia non-Hodgkin’s lymphoma |
Cladribine
|
|
Pyrimidine antagonists include:
|
Fluoropyrimidines
Fluorouracil - S-phase Capecitabine Deoxycytidines Cytarabine Gemcitabine |
|
inhibits thymidylate synthase therefore causing depletion of Thymidylate
Incorporated into DNA and inhibits RNA processing |
5-FU (5-Fluorouracil)
|
|
Used to treat carcinomas of the breast, GI tract, ovary, cervix, urinary bladder, prostate, pancreas, and oropharyngeal areas
Combined with levamisole for Tx of colon cancer |
5-FU
|
|
pyrimidine nucleoside analog
It is activated to 5’ mononucleotide (ara-CMP) by deoxycytidine kinase Inhibits DNA synthesis |
Cytarabine
|
|
AraC is cell-cycle specific agent
It kills cells in the S-phase Its actions are specific for the S phase of the cell cycle |
Cytarabine
|
|
antineoplastic agents that block the reproduction of tumor cells
|
Vinca Alkaloids:Vinblastine, Vincristine, Vinorelbine
|
|
Antitumor agents acting as topoisomerase inhibitors
|
Camptothecins: Topotecan
|
|
Binds to the microtubular protein tubulin in a dimeric form
The drug-tubulin complex adds to the forming end of the microtubules to terminate assembly Depolymerization of the microtubules occurs Leads to mitotic arrest at metaphase, dissolution of the mitotic spindle, and interference with chromosome segregation Cell cycle specific (CCS) agents- M phase |
Vinca Alkaloids
|
|
Alkaloid esters derived from the Western and European Yew
MOA: Mitotic “spindle poison” through the enhancement of tubulin polymerization Note: they affect microtubules |
Taxanes: Paclitaxel and Docetaxel
|
|
Paclitaxel is used to treat:
Docetaxel is used to treat: |
ovarian and advanced breast cancer
advanced breast cancer only |
|
These drugs work by binding to DNA causing
1. intercalation between base pairs and (-) of new RNA or DNA 2. cause DNA strand scission 3. interference with cell replication |
Antibiotics: bleomycin, doxirubicin, mytomycin
|
|
MOA of ?
High-affinity binding to DNA through intercalation Block DNA and RNA synthesis DNA strand scission via effects on Topoisomerase II Binding to membranes altering fluidity Generation of the semiquinone free radical and oxygen radicals |
Anthracylines:Doxorubicin & Daunorubicin
These are antibiotics These drugs are used to treat: Breast, Endometrium, Ovary, Testicle, Thyroid Has major clinical activity in many types of cancer. |
|
A tricyclic pentaglycosidic antibiotic from Streptomyces strains
Binds to DNA through an antibiotic-Mg2+ complex Blocks DNA-directed RNA synthesis Used to treat testicular cancer and hypercalcemia |
Plicamycin
|
|
Bioreductive alkylating agent that undergoes metabolic reductive activation through an enzyme-mediated reduction to generate an alkylating agent that cross-links DNA
Useful in hypoxic tumors Used to treat:Squamous cell carcinoma of the cervix Adenocarcinomas of the stomach, pancreas, and lung 2nd line in metastatic colon cancer |
Mitomycin
|
|
One of the bi- or tri-functional alkylating agents
binds to DNA, which results in single and double strand breaks following free radical formation and inhibition of DNA synthesis Cell cycle specific G2 phase Used for: Testicular cancer Squamous cell carcinomas of the head and neck, cervix, skin, penis, and rectum Lymphomas Intracavitary therapy in ovarian and breast cancers |
Bleomycin
|